Charlie Lees
3y ago
I write about Crohn's disease and ulcerative colitis (IBD), digital health, diet, genetics and the microbiome. I am a passionate educator and innovator. I am a gastroenterologist and I run a busy IBD clinic. I am a Professor of Gastroenterology running a research team improving outcomes for people living with IBD. For more content please see charlielees.com and search Charlie Lees at YouTube.
The optimal monitoring system for IBD will:
continuously and passively track patients during prolonged periods of remission - hiding in the background unless there is a problem
be highly sensitive - to detect early pre-clinical disease flare, and highly specific - so as not to call a false alarm
comprehensively assess and monitor the whole person - think holistic care
be intelligent, adaptive and hyper-personalised
What are the key components of this monitoring system?
wearables devices that passively track symptoms and inflammation levels, quality of life, key behaviours and environmental inputs
toilet tissues that measure calprotectin on the first wipe of the day
next generation predictive biomarkers from serum, stool and more
smart toilets that process biomarkers from stool and urine
whole genome and microbiome sequencing profiles integrated into EHR
machine reading of high-def colonoscopy video, next generation capsule endoscopy devices, digital pathology, MRI scanning and point-of-care intestinal ultrasound via smartphone
A.I. powered predictive analytics - hyper-personalised via smartphone with full EHR integration
Expect to see some version of this in the clinic within 5 years.
Some of these features are close to implementation. Others require development of disruptive technologies or large scale clinical cohorts to enable the precision medicine breakthroughs.
But this is close and it will radically transform outcomes for IBD patients.